Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling

Details for Australian Patent Application No. 2009231841 (hide)

Owner The United States of America, as represented by The Secretary, Department of Health and Human Services

Inventors Athauda, Gagani; Giubellino, Alessio; Peach, Megan; Choyke, Sarah; Nicklaus, Marc; Bottaro, Donald P.; Burke Jr., Terrence; Tan, Nelly; Shi, ZhenDan

Agent Spruson & Ferguson

Pub. Number AU-A-2009231841

PCT Pub. Number WO2009/124013

Priority 61/041,523 01.04.08 US

Filing date 31 March 2009

Wipo publication date 8 October 2009

International Classifications

C07D 213/69 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/22 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/124013 Priority application(s): WO2009/124013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009231849-Processes and apparatus for preventing, delaying or ameliorating one or more symptoms of presbyopia

2009231835-Improvements in computer room security